2.Technical improvement in dealing with chronic atrophic gastritis samples.
Hong-xi MA ; Hai-feng WANG ; Zhuang TIAN ; Chang-yan XU
Chinese Journal of Pathology 2012;41(9):637-638
Adult
;
Aged
;
Aged, 80 and over
;
Female
;
Gastritis, Atrophic
;
diagnosis
;
pathology
;
Gastroscopy
;
methods
;
standards
;
Humans
;
Male
;
Middle Aged
;
Specimen Handling
;
methods
;
Tissue Embedding
;
methods
4.Jianbei manipulation for treating the dislocation of elbow joint.
Zhuang-Ping WANG ; Hong-Wei MA ; Xiao-Ping ZHANG
China Journal of Orthopaedics and Traumatology 2008;21(12):921-921
Adolescent
;
Adult
;
Elbow Joint
;
injuries
;
Female
;
Humans
;
Joint Dislocations
;
therapy
;
Male
;
Manipulation, Orthopedic
;
methods
;
Middle Aged
5.Efficacy and safety of oral vardenafil in the treatment of erectile dysfunction.
Tianming PAN ; Shenrong ZHUANG ; Hongming MA ; Kai HONG ; Wenhao TANG
National Journal of Andrology 2004;10(12):955-959
OBJECTIVETo evaluate the efficacy and safety of vardenafil on men with erectile dysfunction (ED) of various etiologies.
METHODSA total of 88 men with mild to severe erectile dysfunction were enrolled in the randomized, double-blind, placebo-controlled, fixed-dose trial of 12 weeks of treatment with either placebo or 5, 10 and 20 mg of vardenafil.
RESULTSThis study indicated that vardenafil dosages of 5, 10 and 20 mg were significantly superior to placebo for the treatment of ED, on the basis of the primary study endpoints of the EF domain score of the IIEF, diary-recorded success rates for penetration and maintenance of erection during the intercourse and the GAQ. Vardenafil was well tolerated. The incidence of adverse events was higher for vardenafil than for placebo.
CONCLUSIONOral vardenafil therapy has a high efficacy and a low incidence of adverse events for ED patients with mixed etiologies.
Administration, Oral ; Adult ; Aged ; Double-Blind Method ; Erectile Dysfunction ; drug therapy ; Humans ; Imidazoles ; adverse effects ; therapeutic use ; Male ; Middle Aged ; Phosphodiesterase Inhibitors ; adverse effects ; therapeutic use ; Piperazines ; adverse effects ; therapeutic use ; Sulfones ; adverse effects ; therapeutic use ; Triazines ; adverse effects ; therapeutic use ; Vardenafil Dihydrochloride
6.The effect of hyalinized chorda tympani nerve canal in protection of mastoid segment of facial nerve in middle ear surgery.
Yongjun HONG ; Yanli MA ; Peiyun ZHUANG ; Xinlin XU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2013;27(10):487-490
OBJECTIVE:
To investigate the effect of hyalinized chorda tympani nerve canal in mastoid segment to landmark facial nerve in middle ear surgery by means of observing the location relationship between hyalinized chorda tympani nerve canal and facial nerve.
METHOD:
118 cases of cholesteatoma otitis media in our hospital undergoing tympanoplasty from 2008 to 2011 were retrospectively analyzed. In all the cases, the position of horizontal semicircular and fossa incus as well as the hyalinized chorda tympani nerve canal were used for landmark the height of facial ridge and vertical segment of facial nerve.
RESULT:
The chorda tympani nerve of 99 patients were higher than the vertical segment of the facial nerve which were not exposed, and the vertical segment of the facial nerve in 9 patients, which were exposed, were 1-2 mm lower and 2-3 mm ahead or backward than the chorda tympani nerve. The horizontal semicircular and fossa incus were broken in 9 patients, of whom the vertical segments of the facial nerve were 1-2 mm lower and 2-3 mm ahead or backward than the chorda tympani nerve. The chorda tympani nerve of 1 patient were lower than the exposed vertical segment of facial nerve.
CONCLUSION
The hyalinized chorda tympani nerve canal in mastoid segment can landmark the positon of facial ridge, and it would be the complement to the traditional method of landmarking vertical segment of facial nerve, especially for those whose horizontal semicircular canal and fossa incus had been broken.
Adult
;
Aged
;
Cholesteatoma, Middle Ear
;
surgery
;
Chorda Tympani Nerve
;
surgery
;
Female
;
Humans
;
Male
;
Mastoid
;
surgery
;
Middle Aged
;
Otologic Surgical Procedures
;
methods
;
Retrospective Studies
;
Young Adult
7.How chronic prostatitis affects plasminogen activator system.
Kai HONG ; Hui JIANG ; Qingquan XU ; Quan BAI ; Shenrong ZHUANG ; Lulin MA ; Tianming PAN ; Jichuan ZHU
National Journal of Andrology 2004;10(8):586-588
OBJECTIVETo elucidate how chronic prostatitis affects the expression and activity of the plasminogen activator (PA) system and relates to male infertility.
METHODSTwenty-three normal fertile males and 80 chronic prostatitis patients (40 fertile and 40 infertile) were included in this research. SDS polyacrylamide gel electrophoresis and fibrin overlay method were used to estimate the total PA, and tissue PA (tPA), urokinase type PA (uPA) in semen.
RESULTSTotal PA, tPA and uPA highly expressed in normal males, but decreased in the semen of the chronic prostatitis patients of both the fertile and infertile groups. However, there was no significant difference in total PA between the fertile and infertile patients.
CONCLUSIONChronic prostatitis reduces the secretory function and PA synthesis and secretion of the prostate, but the decrease of PA alone does not cause infertility. PA may be one of the tools for estimating the function of the prostate.
Adult ; Case-Control Studies ; Chronic Disease ; Humans ; Infertility, Male ; metabolism ; Male ; Prostatitis ; metabolism ; Semen ; metabolism ; Tissue Plasminogen Activator ; biosynthesis ; Urokinase-Type Plasminogen Activator ; biosynthesis
8.Quality assurance of clinical biochemistry testing:a mualti-center study based reference interval for clinical chemistry tests in the Chinese population
Chuanbao ZHANG ; Xianzhang HUANG ; Lanlan WANG ; Runqing MU ; Baishen PAN ; Jie ZHANG ; Wenxiang CHEN ; Junha ZHUANG ; Hengjian HUANG ; Yueyun MA ; Xiaoou YU ; Wei GUO ; Rui QIAO ; Hong SHANG
Chinese Journal of Laboratory Medicine 2015;(5):301-305
Objective To verify and monitor the performance of accuracy, precision and comparability of 26 clinical biochemical analytes (29 methods) in the six centers involved in multi-centers reference intervals research, and to ensure the reliability of theirmeasurement results.Methods During the period of the systems evaluating, two levels of commercial quality control materials and fresh frozen human serum reference materials were applied to verify the performance of inter-laboratory precision and accuracy of analysis systems. During the period of samples testing, the commercial quality control materials were measured whenever samples were analysed, the fresh frozen serum reference materials were measured once a month.The coefficient of variations (CVs), bias and total errors were calculated to assess the precision, accuracy and comparability.Results Verification of precision and accuracy: ( 1 ) the ranges of CVs of 29 methods in the six laboratory laboratories were 0.4%-6.0%, the CVs of all 29 methods met the criterion . (2) The overall average bias of the analysis systems of 21 analytes (24 methods) ranged from -5.15%( ALT) to 4.46% ( Ur ) .Among 24 methods the overall average bias of TP, Glu-GOD, Ur, Cl, Ca exceeded the acceptable range.The quality assessment during the period of samples testing:(1) The overall average bias ranged from -1.95%(Ca) to 2.92%(Ur), median 1.26%, they all met the requirements of relevant standards.( 2 ) When commercial control materials were tested, the requirements of CVs were fulfilled for most methods in the six laboratories,and the CVs of TP, Alb, Cl, Ca exceeded the acceptable range.The overall average TE of all methods met the quality specification for the C-N controls material.For the C-P control material, only the overall average TE of TP (5.05%) exceeded thearceptable range while the other methods met the requirement in criterion.Conclusions The performance of precision and accuracy of the analysis systems used in the six laboratories passed the verification.During the period of sample testing, the performance of precision and accuracy of the most methods in the 6 laboratories met the requirements of quality specifications, and the overall performance was good.Because of the limitation of current technology the performance of some methods didn't fulfill the requirement of specifications, and need to be improved.
9.Amifostine used in the treatment of patients with myelodysplastic syndrome.
Shu-Xia LI ; Hong-Li ZHU ; Xue-Chun LU ; Hui FAN ; Shan-Qian YAO ; Jian MA ; Qing-Ming YANG ; Li-Li CAI ; Xiao-Meng ZHUANG ; Yang YANG
Journal of Experimental Hematology 2007;15(1):86-90
The study was aimed to investigate the curative effects and adverse effects of amifostine in the treatment of patients with myelodysplastic syndrome (MDS). Amifostine (AMF) was used alone (4/12) or combined with recombinant human erythropoietin (rh-EPO) (8/12) in 12 MDS patients. The therapeutic regimen was adopted with AMF 0.4 g/day for 5 days, then took a break of 2 days and then went on for 3 weeks consecutively, that was reputed as one treatment cycle. rh-EPO 6 000 U was used for 3 days per week. The results showed that 12 patients all attained hematological improvement in peripheral blood. 11 cases showed major effective response rate (91.7%), while 1 case showed minor response rate (8.3%). The effective response rate of hemoglobin, leukocytes and platelets was 100%, 75% and 58.3% respectively. The intervals of red cell transfusions (RCT) in 2 cases living on red cell transfusion before AMF treatment were prolonged after AMF treatments, and the amount of each RCT was decreased obviously. The side effect was usually discomfort of digestive system, but all patients can endure. In conclusion, Amifostine is a potential drug in the treatment of MDS patients with safety especially to those elder patients who often suffered from other multiple organ disfunctions, and the curative effect will be improved by more treatment cycles.
Adult
;
Aged
;
Aged, 80 and over
;
Amifostine
;
adverse effects
;
therapeutic use
;
Drug Therapy, Combination
;
Erythropoietin
;
therapeutic use
;
Female
;
Humans
;
Male
;
Middle Aged
;
Myelodysplastic Syndromes
;
drug therapy
;
Recombinant Proteins
10.Balloon dilatation bronchoplasty in management of bronchial stenosis in children with mycoplasma pneumonia.
Chen MENG ; Hua-feng YU ; Cai-yun NI ; Zhao-zhuang WANG ; Chun-hong DUAN ; Xia LIU ; Zhong-xiao ZHANG ; Jing MA ; Xiao-rong HAN ; Wen-Jing LIU
Chinese Journal of Pediatrics 2010;48(4):301-304
OBJECTIVETo assess the efficacy and safety of balloon dilatation through flexible bronchoscopy in the management of inflammatory stenosis of grade 4-5 bronchus.
METHODThirty patients with inflammatory bronchial stenosis caused by mycoplasmal pneumonia complicated with pulmonary atelectasis were treated with balloon dilatation through fiberoptic bronchoscopy. Before the procedure and after the last operation, therapeutic effect on pulmonary atelectasis were evaluated with CT and all of the patients were followed-up for 1 - 6 months.
RESULTOne to three operations were required to achieve satisfactory dilatation. After balloon dilatation, the average airway diameter increased obviously and the farther airways were opened after the therapy with irrigation. In 25 of 30 cases satisfactory immediate effects were obtained, a narrow airway diameter above expansion significantly increased as compared with preoperative diameter. In 5 children treated with balloon dilatation, the stenosis could not be improved significantly. In 3 patients with hyperplasia of granulation tissue, cryotherapy had to be applied. The operations were ineffective in the other two patients whose course of disease exceeded 3 months. After follow-up periods of 1 - 6 months, chest CT manifestation of expanded sites was improved in 28 patients and atelectasis disappeared. No severe complication was found in any patients.
CONCLUSIONBronchoplasty by balloon dilatation through flexible fiberoptic bronchoscopy is a simple, effective and safe method to treat childhood tracheobronchial stenosis after pulmonary infections.
Bronchial Diseases ; therapy ; Bronchoscopy ; Catheterization ; methods ; Child ; Child, Preschool ; Female ; Humans ; Male ; Pneumonia, Mycoplasma ; therapy ; Pulmonary Atelectasis ; microbiology ; therapy ; Tracheal Stenosis